Patents
More topics under "C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes" (300,877)
C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
C12Q 3 - Condition-responsive control processes (646)
Patents for C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes (2,829)
04/2005
04/07/2005US20050075493 Flea synaptic vesicle nucleic acid molecules, proteins and uses thereof
04/07/2005US20050074895 analysis of protein expression by the reaction of proteins with alkyl-substituted vinyl pyridines as thiol alkylating agents; mass difference is considerably greater than that achieved by isotope tagging
04/07/2005US20050074815 Bioassays incorporate film with chemiluminescent precursor immobilized therewith; polynucleotide/DNA analysis; kits
04/07/2005US20050074794 labeling proteins and other molecules such as lipid and carbohydrates in different samples, then combining these samples for concurrent analysis, for reliable qualitative and quantitative comparison between the samples
03/2005
03/31/2005WO2005028665A2 Campylobacter polypeptides and methods of use
03/31/2005WO2005028664A2 Modulation of programmed necrosis
03/31/2005WO2005028663A2 Operator independent programmable sample preparation and analysis system
03/31/2005WO2005007874A3 Sequential generation of multiple chemiluminescent signals on solid supports
03/31/2005WO2004104213A3 Nucleic acids and polypeptides of c1 bacteriophage and uses thereof
03/31/2005WO2004092394A3 Fluid planar lipid layer-based membrane-anchored ligand system with specific binding pair members and methods of use thereof
03/31/2005WO2004076677A3 Monoclonal antibody production by ebv transformation of b cells
03/31/2005WO2004048598A3 Molecular nephrotoxicology modeling
03/31/2005US20050071087 Systems and methods for detecting biological features
03/31/2005US20050069908 DNA polymerase compositions for quantitative PCR and methods thereof
03/31/2005CA2539108A1 Operator independent programmable sample preparation and analysis system
03/31/2005CA2539074A1 Campylobacter polypeptides and methods of use
03/29/2005CA2139667C Methods and diagnostic kits for determining toxicity utilizing bacterial stress promoters fused to reporter genes
03/24/2005WO2005026381A2 Microarray analysis of host and pathogen gene expression changes in vivo
03/24/2005WO2005026380A2 Bone marrow proliferation assay
03/24/2005WO2005026379A2 The mapping and reconstitution of a conformational discontinuous binding surface
03/24/2005WO2005026375A2 Recombinant carrier molecule for expression, delivery and purification of target polypeptides
03/24/2005WO2005010201A3 Methods and compositions for detecting nucleic acid sequences
03/24/2005WO2004111259A3 Hydrolytic substrates for an analyte-dependent enzyme activation system
03/24/2005WO2004097030A3 Prognostic breast cancer biomarkers
03/24/2005WO2004083450A3 Hyperbranched dendron and methods of synthesis and use thereof
03/24/2005US20050064531 Methods for screening and identifying compounds
03/24/2005US20050064476 Methods for identifying DNA copy number changes
03/24/2005US20050064426 Utilizing probe dependent coefficients to re-scale and correct hybridization data; enhancing accuracy of measured gene expression levels
03/24/2005US20050064394 Viral deletion mutant comprising nucleotide sequences associated with temperance factors for use as tool in detection of modulators which prevent and treat viral infection; viricides; genetic vaccines
03/24/2005US20050063441 High density methods for producing diode-pumped micro lasers
03/24/2005US20050062196 Microfluidic protein crystallography techniques
03/24/2005CA2526720A1 Recombinant carrier molecule for expression, delivery and purification of target polypeptides
03/22/2005US6870047 Magnetic pigment
03/17/2005WO2005024046A2 Methods of detection and notification of bioagent contamination
03/17/2005WO2005024045A2 Primers for use in detecting beta-lactamases
03/17/2005WO2005024044A2 Method for the production of fusion proteins in transgenic mammal milk
03/17/2005WO2005024043A2 Methods for identifying, diagnosing, and predicting survival of lymphomas
03/17/2005WO2005024042A2 Aptamers and methods for their in vitro selection and uses thereof
03/17/2005WO2005024041A2 Alkyl-substituted vinyl pyridines for mass-coded tagging of proteins
03/17/2005WO2005024040A2 TARGET AND METHOD FOR INHIBITION OF BACTERIAL RNA POLYMERASE: MINIMIZED DERIVATIVES OF PEPTIDE ANTIBIOTIC MccJ25
03/17/2005WO2005012543A3 Quantitative method for detecting yessotoxins in fish products based on the activation caused by the toxin in cellular phosphodiesterase and therapeutic usefulness of said activation
03/17/2005WO2005003369A3 Methods for detection and quantification of analytes
03/17/2005WO2004092399A3 Real-time polmerase chain reaction-based genotyping assay for single nucleotide polymorphism
03/17/2005US20050059632 Synthesis of beta-L-2'-deoxy nucleosides
03/17/2005US20050059094 Electrophysiological assay using oocytes that express human ENaC and the use phenamil to improve the effect of ENaC enhancers in assays using membrane potential reporting dyes
03/17/2005US20050059018 Virulence-associated nucleic acids and proteins and uses thereof
03/17/2005CA2538270A1 Primers for use in detecting beta-lactamases
03/17/2005CA2537273A1 Method for the production of fusion proteins in transgenic mammal milk
03/17/2005CA2537254A1 Methods for identifying, diagnosing, and predicting survival of lymphomas
03/16/2005EP1513956A2 Assay to detect replication competent viruses
03/16/2005EP1366360A4 Methods for large scale protein matching
03/16/2005CN1596314A Method of determining a chemotherapeutic regimen based on ercc1 and ts expression
03/10/2005WO2005021778A2 Method and materials for polyamine catalyzed bisulfite conversion of cytosine to uracil
03/10/2005WO2005021777A2 Uses of spatial configuration to modulate protein function
03/10/2005WO2005021776A2 METHODS OF USING MAMMALIAN RNase H AND COMPOSITIONS THEREOF
03/10/2005WO2005021775A2 Method for identifying selective growth inhibitors
03/10/2005WO2004072294A3 Methods and means for nucleic acid sequencing
03/10/2005WO2004057017A3 Detection of small nucleic acids
03/10/2005US20050053958 Using allelic variation in breast cancer genes (BRCA) as diagnostic tool in detection of mammary gland cell proliferative disorders
03/10/2005CA2536621A1 Method for identifying selective growth inhibitors
03/10/2005CA2535902A1 Uses of spatial configuration to modulate protein function
03/09/2005CN1590551A Optimization of cell for endogenous gene activation
03/03/2005WO2005019471A2 Periostin-like factor: compositions and methods for making and using the same
03/03/2005WO2005019470A2 Detecting and profiling molecular complexes
03/03/2005WO2005005652A3 Methods for the identification of inhibitors of c4 long chain base hydroxylase activity in plants
03/03/2005WO2004104211A3 Method for detecting toxic and non-toxic cyanobacteria
03/03/2005US20050050588 Phloem small RNA binding protein (PSRB) for use in enhancing plant growth, systemic resistance, biomass distribution and flowering
03/03/2005US20050048519 Fluidic apparatus comprising biopolymer array for us ein detection of microorganisms in blood; genome diagnostic and metabolic disorders
03/03/2005US20050048488 Expression vector comprising nucleotide sequences coding excitatory amino acid transporter 2 (EAAT2) proteins for use in identifying modulator for treatment and preention of neurological or psychiatric disorder
03/03/2005CA2535510A1 Detecting and profiling molecular complexes
03/02/2005EP1510823A2 Containers for performing polymerase chain reaction
03/02/2005EP1509768A2 Methods for cohort selection and longevity studies
03/02/2005EP1509226A2 Small molecule inhibitors of her2 expression
02/2005
02/24/2005WO2005017190A2 Mitotic kinesin inhibitors
02/24/2005WO2005017187A2 Methods for screening and identifying compounds
02/24/2005WO2005017186A2 Method for rapid identification of alternative splicing
02/24/2005WO2005017185A2 HEPATOCYTE NUCLEAR FACTOR 4α MODULATOR COMPOUNDS
02/24/2005WO2005017183A2 Methylated gene biomarkers for detecting cancer
02/24/2005WO2005017182A2 Multi-color in vitro translation
02/24/2005WO2005017180A2 Immobilization of oligonucleotides and proteins in sugar-containing hydrogels
02/24/2005WO2005017176A2 Methods for identifying risk of melanoma and treatments thereof
02/24/2005WO2004070053A3 cDNA AMPLIFICATION FOR EXPRESSION PROFILING
02/24/2005WO2004070051A3 Chemical proteomics
02/24/2005WO2004055196A3 Method for identifying risk of breast cancer and treatments thereof
02/24/2005WO2004049914A3 Methods for reacting an antigen masking compound with red blood cells with high efficiency
02/24/2005US20050043597 Optical vivo probe of analyte concentration within the sterile matrix under the human nail
02/24/2005US20050043507 Acyl-nucleotide probes and methods of their synthesis and use in proteomic analysis
02/24/2005US20050042705 Methods for the identification of inhibitors of mannosyltransferase as antibiotics
02/24/2005US20050042649 Arrayed biomolecules and their use in sequencing
02/24/2005US20050042601 Detection of herpes simplex virus types 1 and 2 by nucleic acid amplification
02/24/2005CA2535332A1 Method for rapid identification of alternative splicing
02/24/2005CA2534729A1 Mitotic kinesin inhibitors
02/24/2005CA2533924A1 Immobilization of oligonucleotides and proteins in sugar-containing hydrogels
02/24/2005CA2530748A1 Methylated gene biomarkers for detecting cancer
02/23/2005EP1507875A2 Assay for identifying inhibitors of fc gamma riii signaling
02/17/2005WO2005014850A2 Systems and methods for analyzing nucleic acid sequences
02/17/2005WO2005014849A2 Genes associated with responses to neuropathic pain
02/17/2005WO2005014848A2 IMPROVED ELECTROPHYSIOLOGICAL ASSAYS USING OOCYTES THAT EXPRESS HUMAN ENaC AND THE USE OF PHENAMIL TO IMPROVE THE EFFECT OF ENaC ENHANCERS IN ASSAYS USING MEMBRANE POTENTIAL REPORTING DYES
02/17/2005WO2005014846A2 Methods for identifying risk of breast cancer and treatments thereof
02/17/2005WO2004092396A3 Flap endonuclease 1 (fen1) regulatory sequences and uses thereof
1 ... 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 ... 29